2 Overlooked Oil Stocks to Buy Now Before They Soar
M&S buys mothballed fulfilment centre from Asos for £67m
3 Small-Cap Stocks to Buy Before May 15
Ardmore Shipping Q1 Earnings Call Highlights
Ardmore Shipping: Doubling The Payout Turns It Into A Buy (Ratings Upgrade)
Ardmore Shipping Corporation (ASC) Q1 2026 Earnings Call Transcript
Ardmore Shipping Corporation Announces Financial Results For The Three Months Ended March 31, 2026
Ardmore Shipping Announces First Quarter 2026 Conference Call and Webcast
Ardmore Shipping Provides Update on Fleet Investment, Dividend Policy, and Vessel Sale
Ascletis Completes Enrollment in U.S. Phase II Study of ASC30, an Oral Small Molecule GLP-1R Agonist, for the Treatment of Diabetes
Asos climbs as profit margins show improvement, with analysts wanting more stability
A Look at Ardmore Shipping Corp (ASC) After 4.8% Gain -- GF Value $9.16 vs Price $16.24
Ascletis Announces Fixed-Dose Combination of ASC30, Once-Daily Oral Small Molecule GLP-1R Agonist, and ASC39, Once-Daily Oral Small Molecule Amylin-Selective Amylin Receptor Agonist, for Clinical Development
ZyVersa Therapeutics Reports Full Year 2025 Financial Results and Provides Business Update
Ardmore Shipping Files 2025 Annual Report on Form 20-F
Brokerages Set Ardmore Shipping Corporation (NYSE:ASC) Target Price at $13.67
Ardmore Shipping Corporation (ASC) Analyst/Investor Day Transcript
Ardmore Shipping Corporation Announces Financial Results For The Three and Twelve Months Ended December 31, 2025
Ascletis Selects Oral Amylin Receptor Peptide Agonist, ASC36, for Clinical Development
Sagimet Announces Positive 52-Week Data from License Partner Ascletis' Open-Label Phase 3 Clinical Trial Evaluating the Long-Term Safety of ASC40 (Denifanstat) Tablets in Patients with Moderate to Severe Acne
Ardmore Shipping Announces 2026 Investor Day in New York
Ascletis Announces Positive Topline Results from Its Phase III Open-Label Study of Denifanstat (ASC40), a First-in-Class, Once-Daily Oral FASN Inhibitor for Acne
Comparing United Maritime (NASDAQ:USEA) and Ardmore Shipping (NYSE:ASC)
Ascletis Announces First Participants Dosed in a 13-week U.S. Phase II Study with ASC30, an Oral Small Molecule GLP-1R Agonist for the Treatment of Diabetes
Ardmore Shipping Corporation (NYSE:ASC) Receives $13.67 Consensus Price Target from Brokerages
Ardmore Shipping (NYSE:ASC) Stock Crosses Below 50 Day Moving Average – Time to Sell?
Ardmore Shipping Corporation: A Modern Fleet Trading At A Discount
Ascletis Announces Positive Topline Results from U.S. Phase I Study of ASC50, a Potential Best-in-Class Oral Small Molecule IL-17 Inhibitor
Ascletis Announces China National Medical Products Administration Acceptance of New Drug Application for Denifanstat (ASC40), a First-in-Class FASN Inhibitor for Acne Treatment
American Century Companies Inc. Grows Holdings in Ardmore Shipping Corporation $ASC
Ascletis Announces Co-formulation of ASC36, Once-Monthly Next-Generation Amylin Receptor Agonist and ASC35, Once-Monthly Next-Generation GLP-1R/GIPR Dual Agonist for Clinical Development
Ardmore Shipping Corporation (ASC) Q3 2025 Earnings Call Transcript
Ardmore Shipping Corporation Announces Financial Results For The Three and Nine Months Ended September 30, 2025
Ascletis Presents Full Analysis of Phase Ib Study of ASC30 Oral Tablet, Phase Ib Study of ASC30 Injection, and Preclinical Study of Combination of ASC31 and ASC47 at ObesityWeek® 2025
Ardmore Shipping (ASC) Expected to Announce Quarterly Earnings on Wednesday
Ascletis Selects a Best-in-Class Once-Monthly Subcutaneously Administered Amylin Receptor Agonist, ASC36, for Clinical Development
Duly Health and Care Expands Outpatient Surgery Access Through Minority Share Acquisition of Valley ASC in Partnership with Surgery Partners
Ascletis to Present Study Results of ASC30 Oral Tablet, ASC30 Injection, and Combination of ASC31 and ASC47 at ObesityWeek® 2025
Ardmore Shipping Announces Third Quarter 2025 Conference Call and Webcast
Ardmore Shipping: A Compelling Buy At 0.66x NAV With Rising MR Rates (Upgrade)
Ascletis Completes Denifanstat (ASC40) Pre-NDA Consultation with China National Medical Products Administration
Ardmore Shipping (ASC) Stock Sinks As Market Gains: Here's Why
Is Ardmore Shipping (ASC) a Buy as Wall Street Analysts Look Optimistic?
Ardmore Shipping Corporation (ASC) Is a Trending Stock: Facts to Know Before Betting on It
TKCM is Entering the 700 Billion Dollar Affordable Housing Market
Ardmore Shipping (ASC) Stock Falls Amid Market Uptick: What Investors Need to Know
Apollo Announces Launch of Apollo Sports Capital
New Strong Buy Stocks for September 24th
Best Value Stocks to Buy for September 24th